Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SUNIL PHARMACY | 1 | ₹630 |
| 2 | Schedule 2 | EXCEL LIFE CARE DISTRIBUTOR | 2 | ₹144.90 |
| 3 | Schedule 3 | SHREE ASHTAVINAYAK SALES CORPORATION | 4 | ₹2,635 |
| 4 | Schedule 4 | sk life sciences | 2 | ₹870 |
| 5 | Schedule 5 | sk life sciences | 3 | ₹320 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
29 Dec 2023, 9:00 amClosed
ECHS RE 96
5755852
GEM/2023/B/4355360
Two Packet Bid
Isoniazid 300 mg Tab,Fluconazole 50 mg Cap Tab,Azathioprine 50mg Tab,Hydroxyurea 500 mg tab,Imatini
30 days
Maharashtra; Nashik
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹3
30%
Exempted
1 Jan 2024
16 Dec 2023
29 Dec 2023
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Isoniazid 300 mg Tab | 280 | No | NASHIK CITY | 30 |
| 2 | Fluconazole 50 mg Cap Tab | 90 | No | NASHIK CITY | 30 |
| 3 | Azathioprine 50mg Tab | 1,700 | No | NASHIK CITY | 30 |
| 4 | Hydroxyurea 500 mg tab | 300 | No | NASHIK CITY | 30 |
| 5 | Imatinib Mesylate 100mg tab | 40 | No | NASHIK CITY | 30 |
| 6 | Methotrexate 2 dot 5mg Tab | 2,100 | No | NASHIK CITY | 30 |
| 7 | Methotrexate 5 mg Tab | 2,400 | No | NASHIK CITY | 30 |
| 8 | Tamoxifen Citrate 20 mg Tab | 300 | No | NASHIK CITY | 30 |
| 9 | Rasaglinide 1 mg Tab | 90 | No | NASHIK CITY | 30 |
| 10 | Levodopa 125 mg tab | 1,900 | No | NASHIK CITY | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5755852.pdf
GEM_BID
re_96_2023-12-16-15-04-53_8d862154070da585eb6ff74cf7069458.pdf
BOQ
boq_item_sample_file_2023-12-16-15-04-53_53aae4cd3939f7d84d76a384f67e5b85.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .